Selective depletion of alloreactive T cells and study of anti-tumor activity of specific T cell clones in patients with leukemia;Selektivní deplece aloreaktivních T lymfocytů a studium protinádorové aktivity specifických klonů T lymfocytů u pacientů s leukémií

Klinicka Onkologie

Volumn 21, Issue 3, 2008, Pages 104-109

  Matějková, Eva ^a   Ocadlikova D ^a   Smejkalova J ^a   Muzikova J ^a   Raida, L ^b   Tousovska K ^c   Pacasova R ^c   Nenickova M ^c   Tesarova E ^c   Sterba J ^c   Indrak K ^b   Michalek J ^a,c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Graft versus host disease; Hematopoietic stem cell transplantation; Immunotherapy; Lymphocyte depletion

Indexed keywords

CD4 ANTIGEN; IMMUNOTOXIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PATIENT; CD4+ T LYMPHOCYTE; CELL CLONE; CELL STIMULATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CZECH REPUBLIC; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE; TISSUE INJURY;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; CHILD; CLONE CELLS; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKEMIA; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MIDDLE AGED; RICIN; T-LYMPHOCYTES; YOUNG ADULT;

EID: 46449110247     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Horowitz MM. Uses and growth of hematopoietic cell transplantation. In: Hematopoietic Cell Transplantation. 2 ed. Thomas ED, Blume KG, Forman SJ, eds. Blackwell Science, Inc., Maiden, MA, 2000: 8-15.
2. Mavroudis DA, Dermime S, Molldrem J, et al. Specific depletion of alloreactive T cells in HLA-identical siblings: a method for separating graft-versus-host and graft-versus-leukemia reactions. Br J Haematol 1998, 101: 565-570.
3. Collins RH Jr, Schpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444.
4. Childs R., Chernoff A., Contentin N. et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. The New England Journal of Medicine 2000, 343 (11):750-758
5. Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood 2004, 103: 767-776.
6. Ferrara JL, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant 1999; 5: 347-356.
7. Marmont AM, Horowitz MM, Gale RP, et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
8. de Gast GC, Gratama JW, Verdonck LF, et al. The influence of T cell depletion on recovery of T cell proliferation to herpesviruses and Candida after allogeneic bone marrow transplantation. Transplantation 1989; 48: 111-115.
9. Barrett AJ, Mavroudis D, Tisdale J et al. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versusleukemia effect. Bone Marrow Transplant. 1998;21:543-551.
10. Amrolia PJ, Muccioli-Casadei G, Huls H et al. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. Blood 2006;108:1797-1808.
11. Vaclavkova P, Cao Y, Wu LK, Michalek J, Vitetta ES. A comparison of an anti-CD25 immunotoxin, Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro. Bone Marrow Transplant. 2006;37:559-567.
12. Chen BJ, Cui X, Liu C, Chao NJ. Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process. Blood 2002;99:3083-3088.
13. Ho VT. Soiffer RJ. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001; 98: 3192-3204.
14. Michálek J., Collins R.H., Durrani H.P., Václavková P., Ruff L.E., Douek D.C., Vitetta E.S.: Definitive separation of graft-versus-leukemia and graft-versus-host specific CD4+ T cell clones by virtue of their T cell receptor beta locus sequences. Proc Natl Acad Sci USA 2003, 100: 1180-4.
15. Michálek J, Collins RH, Vitetta ES. The effect of chain immunotoxin different enhancers on the ability of an anti-CD25 ricin a to deplete cells which are activated in an MLR. Blood 2000; 96: 312b.
16. Michálek J., Collins R.H., Vitetta E.S.: Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin. Neoplasma 2003, 50: 296-9.
17. Montagna D, Yvon E, Calcaterra V, et al. Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity. Blood 1999; 93: 3550-3557.